An oldie but goodie, tops the list for March 2017! Data integrity is a hot topic in the pharmaceutical industry right now. Hear from industry experts about the difference between data quality and data integrity.
Looking Ahead – 2017 Pharmaceutical Industry Trends
Learn from six industry experts as they tackle the hard questions on what the global pharmaceutical industry needs to move forward from the most important developments and innovations to the biggest hurdles of 2017.
Are you in the development and/or implementation phase of an automated production system? Are you considering revising your data integrity strategy plan? Get the GAMP® guidelines you need to achieve your desired outcome.
This article was up for the 2016 Article of the Year Awards by Pharmaceutical Engineering® magazine. Learn how process validation and quality risk management have impacted the biopharmaceutical manufacturing industry and what's in store for the future.
Pharmaceutical Engineering® magazine published a quarterly report on Quality Culture, in the November/December 2016 issue. This article from the report reviews how quality culture is impacting the pharmaceutical industry and what you can do at your organization to implement a culture of quality.
Are you considering joining ISPE? Or maybe you’ve recently joined the society or are a longtime member looking to better understand all the benefits available to you. If so, you’ve come to the right place!
ATMPs are based on genes, cells or tissues delivered to patients to provide a therapeutic benefit based on a specific target of interest. Often referred to as ‘Personalised Medicine’. A sector of healthcare that is rapidly evolving and expanding with some unique challenges such as microbial contamination and product variability. Traditional manufacturing processes are for synthetically derived...
GAMP® 5 Second Edition is here! Since its publication, GAMP® 5 has been far and away the leading international guidance on GxP computerized systems validation and compliance, and it was time to update our guidance to...